KDR and hepatocellular carcinoma: miR-199-3p, another miRNA that can target VEGFR1, VEGFR2, and the ligand VEGFA (68), is frequently down-regulated in HCC and it has been shown to have in vitro and in vivo anti-tumor activity in HCC models (68, 70).